MedPath

Physical Exercise in Hypertension, Randomised Clinical Trial

Not Applicable
Completed
Conditions
Hypertension
Registration Number
NCT00218972
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

Endurance training has a documented effect on hypertension. However, only low to moderate training intensity has so far been studied. High aerobic intensity should, from physiological considerations, prove more effective in also reducing high blood pressure. The present study is a randomised comparison of high versus moderate intensity versus training in groups, and general advice on 24 hour blood pressure in hypertensives. The training period is 12 weeks, with follow-up after 1 year. Maximum oxygen uptake, quality of life, left ventricular function and blood vessel reactivity are also measured.

Detailed Description

Endurance training has documented effect on blood pressure in hypertension. However, only low to moderate training intensity has so far been studied. Higher aerobic intensity based on individual measurements of maximum oxygen uptake is more efficient in increasing oxygen uptake, and might prove more effective in lowering blood pressure. Group training, on the other hand is not individualised, but less personnel required and may prove more cost effective. Endurance training is shown to improve both systolic and diastolic left ventricular function, as well as endothelial function. Both can be measured non-invasively by ultrasound.

The study is an open, randomised study with four arms, comparing:

* High aerobic intensity interval training

* Moderate aerobic intensity training

* Group training

* Controls receiving standard advice on lifestyle and training

Training effect is measured by Max. Oxygen uptake, blood pressure by continuous 24 hour ambulatory measurement, Left ventricular function by echo Doppler and endothelial function by flow mediated vasodilation by ultrasound.

The effect of exercise on blood pressure is dependent on continued training. All patients will be followed up after one year.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
88
Inclusion Criteria
  • Essential hypertension grade 1 - 2 without medical treatment
Exclusion Criteria
  • End organ damage
  • Two or more cardiovascular risk factors
  • Diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
24 hour blood pressure12 weeks
Secondary Outcome Measures
NameTimeMethod
Maximum oxygen uptake12 weeks
Endothelial function12 weeks
Echocardiographic left ventricular function12 weeks
Quality of life12 weeks

Trial Locations

Locations (1)

Norwegian University of Science and Technology

🇳🇴

Trondheim, Norway

Norwegian University of Science and Technology
🇳🇴Trondheim, Norway

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.